Mga Batayang Estadistika
| CIK | 1145460 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to ImageneBio, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| February 14, 2018 |
ALR / Alere Inc. / Invesco Ltd. - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5 )* Alere Inc ** (Name of Issuer) Common Stock (Title of Class of Securities) 01449J105 ** (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedu |
|
| February 6, 2018 |
AXTA / Axalta Coating Systems Ltd. / IRIDIAN ASSET MANAGEMENT LLC/CT Passive Investment SC 13G/A 1 axalta13ga112312017.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Axalta Coating Systems Ltd. (Name of Issuer) Common Stock (Title of Class of Securities) G0750C108 (CUSIP Number) December 31, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to de |
|
| February 6, 2018 |
ALR / Alere Inc. / IRIDIAN ASSET MANAGEMENT LLC/CT Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Alere Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 01449J105 (CUSIP Number) December 31, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| November 8, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-16789 ALERE INC. (Exact name of registrant as specified in its charter) |
|
| November 8, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-16789 ALERE INC. (Exact name of registrant as specified in its charter) |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
S-8 POS 1 a17-2512820s8pos.htm S-8 POS Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statem |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
S-8 POS 1 a17-2512826s8pos.htm S-8 POS Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statem |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 3, 2017 |
Registration Statement No. 333-209524 Registration Statement No. 333-203318 Registration Statement No. 333-199308 Registration Statement No. 333-199307 Registration Statement No. 333-191103 Registration Statement No. 333-191101 Registration Statement No. 333-183064 Registration Statement No. 333-183063 Registration Statement No. 333-170842 Registration Statement No. 333-161373 Registration Stateme |
|
| November 2, 2017 |
Registration Statement No. 333-128017 Registration Statement No. 333-124461 Registration Statement No. 333-116659 Registration Statement No. 333-110716 Registration Statement No. 333-110715 Registration Statement No. 333-107288 Registration Statement No. 333-102577 Registration Statement No. 333-85658 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT |
|
| November 2, 2017 |
Registration Statement No. 333-128017 Registration Statement No. 333-124461 Registration Statement No. 333-116659 Registration Statement No. 333-110716 Registration Statement No. 333-110715 Registration Statement No. 333-107288 Registration Statement No. 333-102577 Registration Statement No. 333-85658 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT |
|
| November 2, 2017 |
Registration Statement No. 333-128017 Registration Statement No. 333-124461 Registration Statement No. 333-116659 Registration Statement No. 333-110716 Registration Statement No. 333-110715 Registration Statement No. 333-107288 Registration Statement No. 333-102577 Registration Statement No. 333-85658 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT |
|
| November 2, 2017 |
POS AM 1 a17-251265posam.htm POS AM Registration Statement No. 333-128017 Registration Statement No. 333-124461 Registration Statement No. 333-116659 Registration Statement No. 333-110716 Registration Statement No. 333-110715 Registration Statement No. 333-107288 Registration Statement No. 333-102577 Registration Statement No. 333-85658 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, |
|
| November 2, 2017 |
Registration Statement No. 333-128017 Registration Statement No. 333-124461 Registration Statement No. 333-116659 Registration Statement No. 333-110716 Registration Statement No. 333-110715 Registration Statement No. 333-107288 Registration Statement No. 333-102577 Registration Statement No. 333-85658 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT |
|
| November 2, 2017 |
Registration Statement No. 333-128017 Registration Statement No. 333-124461 Registration Statement No. 333-116659 Registration Statement No. 333-110716 Registration Statement No. 333-110715 Registration Statement No. 333-107288 Registration Statement No. 333-102577 Registration Statement No. 333-85658 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT |
|
| November 2, 2017 |
Registration Statement No. 333-128017 Registration Statement No. 333-124461 Registration Statement No. 333-116659 Registration Statement No. 333-110716 Registration Statement No. 333-110715 Registration Statement No. 333-107288 Registration Statement No. 333-102577 Registration Statement No. 333-85658 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT |
|
| November 2, 2017 |
Registration Statement No. 333-128017 Registration Statement No. 333-124461 Registration Statement No. 333-116659 Registration Statement No. 333-110716 Registration Statement No. 333-110715 Registration Statement No. 333-107288 Registration Statement No. 333-102577 Registration Statement No. 333-85658 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT |
|
| October 16, 2017 |
QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 4, 2017 |
QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 4, 2017 |
QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. |
|
| October 4, 2017 |
EX-99.(A)(5)(F) 2 a2233446zex-99a5f.htm EX-99.(A)(5)(F) Exhibit 99.(a)(5)(F) News Release Abbott Completes Cash Tender Offer for Series B Convertible Perpetual Preferred Stock of Alere Inc. ABBOTT PARK, Ill., Oct. 4, 2017 — Abbott announced today that it has successfully completed its previously announced tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Pr |
|
| October 3, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 OMB APPROVAL OMB Number: 3235-0080 Expires: March 31, 2018 Estimated average burden hours per response. . . . . . 1.00 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-16789 ISSUER: ALERE INC.; EXCHANGE: NEW YORK STOCK EXCHAN |
|
| October 3, 2017 |
8-K 1 a17-2109248k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2017 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Co |
|
| October 3, 2017 |
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on October 16, 2017, pursuant to the provisions of Rule 12d2-2 (a). |
|
| October 2, 2017 |
Exhibit 99.(a)(5)(E) News Release Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. ABBOTT PARK, Ill., Oct. 2, 2017 Abbott announced today that it is extending its previously announced tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stock (the Preferred S |
|
| October 2, 2017 |
QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. |
|
| September 19, 2017 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 15, 2017 Date of Report (Date of earliest event reported) ALERE INC. (Exact name of registrant as specified in its charter) Delaware 1-16789 04-3565120 (State of Incorporation) (Commission File Number) (IRS Employer Identif |
|
| September 19, 2017 |
Exhibit Exhibit 10.1 AMENDED AND RESTATED TRIAGE PURCHASE AGREEMENT by and among ALERE INC., QUIDEL CARDIOVASCULAR INC., for purposes of Sections 6.13 and 12.15, QUIDEL CORPORATION and for the limited purposes herein set forth, ABBOTT LABORATORIES Dated as of September 15, 2017 TABLE OF CONTENTS ARTICLE I DEFINITIONS 1 SECTION 1.01. Certain Defined Terms. 2 SECTION 1.02. Definitions. 11 SECTION 1. |
|
| September 19, 2017 |
Exhibit Exhibit 10.2 AMENDED AND RESTATED PURCHASE AGREEMENT by and among ALERE INC., QUIDEL CARDIOVASCULAR, INC., for purposes of Section 11.15, QUIDEL CORPORATION and for the limited purposes herein set forth, ABBOTT LABORATORIES Dated as of September 15, 2017 TABLE OF CONTENTS ARTICLE I DEFINITIONS 1 SECTION 1.01. Certain Defined Terms. 1 SECTION 1.02. Definitions. 12 SECTION 1.03. Interpretati |
|
| September 18, 2017 |
Exhibit 99.(a)(5)(D) News Release Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. ABBOTT PARK, Ill., Sept. 18, 2017 Abbott announced today that it is extending its previously announced tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stock (the Preferred |
|
| September 18, 2017 |
QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. |
|
| September 1, 2017 |
EX-99.(A)(5)(C) 2 a2233124zex-99a5c.htm EX-99.(A)(5)(C) Exhibit 99.(a)(5)(C) News Release Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. ABBOTT PARK, Ill., Sept. 1, 2017 — Abbott announced today that it is extending its previously announced tender offer to purchase for cash all outstanding shares of Series |
|
| September 1, 2017 |
SC TO-T/A 1 a2233124zscto-ta.htm SC TO-T/A QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 2) ALERE INC. (Name of Subject Company) ABBOTT LABORATORIES (Offeror) (Names of Filing Persons) S |
|
| August 21, 2017 |
QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. |
|
| August 21, 2017 |
QuickLinks - Click here to rapidly navigate through this document Exhibit 99.(a)(5)(B) Supplemental Letter to Holders Relating to the Offer to Purchase for Cash All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. at $402.00 Net Per Share of Series B Convertible Perpetual Preferred Stock by Abbott Laboratories THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P |
|
| August 21, 2017 |
Exhibit 99.(a)(5)(A) News Release Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. ABBOTT PARK, Ill., Aug. 14, 2017 ? Abbott announced today that it is extending its previously announced tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stock (the ?Preferred |
|
| August 3, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2017 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| August 3, 2017 |
Alere Reports Second Quarter 2017 Financial Results EX-99.1 Exhibit 99.1 Alere Reports Second Quarter 2017 Financial Results WALTHAM, Mass., August 3, 2017 ? Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced its financial results for the second quarter ended June 30, 2017. Second Quarter 2017 ? Total revenue was $558 million, a 9% decrease compared to $610 million in the prior year period. ? Non-GAAP organic growth |
|
| August 3, 2017 |
ALR / Alere Inc. FORM 10-Q (Quarterly Report) Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| July 21, 2017 |
Submission Proof - I:\Edgar\Alere Inc\Current Projects\eh17006658k\eh17006658k.gfp UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 21, 2017 Date of Report (Date of earliest event reported) ALERE INC. (Exact name of registrant as specified in its charter) Delaware 1-16789 04-3 |
|
| July 21, 2017 |
Submission Proof - I:\Edgar\Alere Inc\Current Projects\eh17006658k\eh17006658k.gfp UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14D-9 (RULE 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(D)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 ALERE INC. (Name of Subject Company) ALERE INC. (Name of Persons Filing Statement) SERIES B CONVERTIBLE PERPETUAL P |
|
| July 17, 2017 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 15, 2017 Date of Report (Date of earliest event reported) ALERE INC. (Exact name of registrant as specified in its charter) Delaware 1-16789 04-3565120 (State of Incorporation) (Commission File Number) (IRS Employer Identificati |
|
| July 17, 2017 |
Exhibit 10.2 PURCHASE AGREEMENT by and among ALERE INC., QTB ACQUISITION CORP., for purposes of Section 11.15, QUIDEL CORPORATION and for the limited purposes herein set forth, ABBOTT LABORATORIES Dated as of July 15, 2017 TABLE OF CONTENTS ARTICLE I DEFINITIONS 1 SECTION 1.01. Certain Defined Terms. 1 SECTION 1.02. Definitions. 11 SECTION 1.03. Interpretation. 12 ARTICLE II PURCHASE AND SALE 13 S |
|
| July 17, 2017 |
EX-10.1 2 eh1700795ex1001.htm EXHIBIT 10.1 Exhibit 10.1 TRIAGE PURCHASE AGREEMENT by and among ALERE INC., QTB ACQUISITION CORP., for purposes of Sections 6.13 and 12.15, QUIDEL CORPORATION and for the limited purposes herein set forth, ABBOTT LABORATORIES Dated as of July 15, 2017 TABLE OF CONTENTS ARTICLE I DEFINITIONS 1 SECTION 1.01. Certain Defined Terms. 1 SECTION 1.02. Definitions. 11 SECTIO |
|
| July 17, 2017 |
QuickLinks - Click here to rapidly navigate through this document Exhibit (a)(1)(C) Offer To Purchase For Cash All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. |
|
| July 17, 2017 |
QuickLinks - Click here to rapidly navigate through this document Exhibit (a)(1)(B) LETTER OF TRANSMITTAL To Tender Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. |
|
| July 17, 2017 |
Exhibit (a)(1)(E) This announcement is neither an offer to purchase nor a solicitation of an offer to sell shares of Preferred Stock (as defined below), and the provisions herein are subject in their entirety to the provisions of the Offer (as defined below). |
|
| July 17, 2017 |
EX-99.(A)(1)(D) 5 a2232668zex-99a1d.htm EX-99.(A)(1)(D) Exhibit (a)(1)(D) Offer To Purchase For Cash All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. at $402.00 Net Per Share of Series B Convertible Perpetual Preferred Stock Pursuant to the Offer to Purchase, dated as of July 17, 2017 by Abbott Laboratories THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 |
|
| July 17, 2017 |
QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 ALERE INC. |
|
| July 17, 2017 |
QuickLinks - Click here to rapidly navigate through this document Exhibit (a)(1)(A) Offer to Purchase for Cash All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. |
|
| July 17, 2017 |
EX-99.(A)(1)(F) 7 a2232668zex-99a1f.htm EX-99.(A)(1)(F) Exhibit (a)(1)(F) News Release Abbott Commences Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. ABBOTT PARK, Ill., July 17, 2017 — Abbott announced today that it is commencing a tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stoc |
|
| July 7, 2017 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders 8-K 1 d423000d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2017 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Co |
|
| July 7, 2017 |
Alere Shareholders Approve Amended Merger with Abbott EX-99.1 Exhibit 99.1 Alere Shareholders Approve Amended Merger with Abbott WALTHAM, Mass., July 7, 2017 ? Alere Inc. (NYSE: ALR) (the ?Company?), a global leader in rapid diagnostic tests, today announced that its shareholders have voted to approve the previously announced amended merger with Abbott. In a final count of the voting results, approximately 63 million of votes cast at a special meetin |
|
| June 21, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| June 14, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 d408385d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2017 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commis |
|
| June 14, 2017 |
Alere Reports First Quarter 2017 Financial Results EX-99.1 Exhibit 99.1 Alere Reports First Quarter 2017 Financial Results WALTHAM, Mass., June 14, 2017 ? Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced its financial results for the first quarter ended March 31, 2017. First Quarter 2017 Results ? Total revenue was $588 million, compared to $587 million in the prior year period. ? Global influenza sales were $59 m |
|
| June 14, 2017 |
ALR / Alere Inc. FORM 10-Q (Quarterly Report) Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| June 6, 2017 |
Alere DEFINITIVE PROXY STATEMENT Definitive Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 5, 2017 |
Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2016 Financial Results EX-99.1 Exhibit 99.1 Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2016 Financial Results WALTHAM, Mass., June 5, 2017 ? Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it has filed its Form 10-K and reported its financial results for the fourth quarter and full year ended December 31, 2016. Full Year 2016 Results ? Revenue for the full year 20 |
|
| June 5, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2017 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Emp |
|
| June 5, 2017 |
EX-21.1 Exhibit 21.1 List of Subsidiaries of Alere Inc. Name of Subsidiary State or Jurisdiction of Incorporation % of ownership Amedica Biotech, Inc. California 100 % Ameditech Inc. California 100 % Redwood Toxicology Laboratory, Inc. California 100 % Alere Connect, LLC Delaware 100 % Alere Holdco, Inc. Delaware 100 % Alere Home Monitoring, Inc. Delaware 100 % Alere International Holding Corp. De |
|
| June 5, 2017 |
SUMMARY OF DIRECTOR COMPENSATION EX-10.8 Exhibit 10.8 SUMMARY OF DIRECTOR COMPENSATION The following sets forth the compensation payable to Alere Inc.’s non-employee directors as of December 31, 2016: 1. Base Cash Compensation • Each non-employee director will receive Base Cash Compensation of $80,000 annually. Payments are made quarterly in arrears. 2. Additional Cash Compensation • Each non-employee director will also receive t |
|
| June 5, 2017 |
ALR / Alere Inc. FORM 10-K (Annual Report) Form 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 31, 2017 |
Alere Inc. Conflict Minerals Report For The Year Ended December 31, 2016 EX-1.01 Exhibit 1.01 Alere Inc. Conflict Minerals Report For The Year Ended December 31, 2016 This Conflict Minerals Report of Alere Inc., including its consolidated subsidiaries (herein referred to as ?Alere,? the ?Company,? ?we,? ?us,? or ?our?), for the year ended December 31, 2016 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the ?1934 Act?). The Rule was ad |
|
| May 31, 2017 |
SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ALERE INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation or Organization) (Commission File Number) (I.R.S. Employer Identification No.) 51 Sawyer Road, Suite 200, Waltham, Massachusetts 02459 (Address of |
|
| May 30, 2017 |
Alere (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30 , 2017 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Em |
|
| May 30, 2017 |
FOURTH AMENDMENT TO CREDIT AGREEMENT Exhibit 10.1 FOURTH AMENDMENT TO CREDIT AGREEMENT THIS FOURTH AMENDMENT TO CREDIT AGREEMENT (this “ Fourth Amendment”), dated as of May 30, 2017, among ALERE INC., a Delaware corporation (the “ Borrower”), each of the Guarantors (as defined in the Credit Agreement referred to below) party hereto, the Lenders (as defined in the Credit Agreement referred to below) party hereto, GOLDMAN SACHS BANK US |
|
| May 22, 2017 |
Alere Announces Update on Form 10-K and Provides Preliminary Unaudited Financial Results EXHIBIT 99.1 Alere Announces Update on Form 10-K and Provides Preliminary Unaudited Financial Results WALTHAM, Mass ., May 22, 2017 ? Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced certain preliminary unaudited financial information for the fourth quarter and full fiscal year ended December 31, 2016 and the first quarter of 2017 ended March 31, 2017. The Company |
|
| May 22, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2017 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1‑16789 04‑3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Emp |
|
| May 22, 2017 |
PREM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 11, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For period ended: March 31, 2017 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on Form N-SAR For the transition period ended: If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: PART I REGISTRANT INFORMATION Alere Inc. |
|
| May 1, 2017 |
Unassociated Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 1, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2017 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1?16789 04?3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS E |
|
| April 24, 2017 |
THIRD AMENDMENT TO CREDIT AGREEMENT Exhibit 10.1 THIRD AMENDMENT TO CREDIT AGREEMENT THIS THIRD AMENDMENT TO CREDIT AGREEMENT (this “ Third Amendment”), dated as of April 24, 2017, among ALERE INC., a Delaware corporation (the “ Borrower”), each of the Guarantors (as defined in the Credit Agreement referred to below) party hereto, the Lenders (as defined in the Credit Agreement referred to below) party hereto, GOLDMAN SACHS BANK USA |
|
| April 24, 2017 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2017 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS E |
|
| April 17, 2017 |
8-K 1 eh17005188k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8–K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 12, 2017 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1‑16789 04‑3565120 (State or Other Jurisdiction of Incorporation) |
|
| April 14, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| April 14, 2017 |
Alere FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8?K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2017 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1?16789 04?3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS E |
|
| April 14, 2017 |
EXHIBIT 99.1 News Release Abbott and Alere Amend Terms of Merger Agreement ABBOTT PARK, Ill. and WALTHAM, Mass., April 14, 2017 ? Abbott and Alere Inc. announced today that the companies have agreed to amend the existing terms of their agreement for Abbott's acquisition of Alere. Under the amended terms, Abbott will pay $51 per common share to acquire Alere, for a new expected equity value of appr |
|
| April 14, 2017 |
EXHIBIT 2.1 AMENDMENT TO AGREEMENT AND PLAN OF MERGER This AMENDMENT, dated as of April 13, 2017 (this ? Amendment?) to the Agreement and Plan of Merger (the ? Agreement?), dated as of January 30, 2016, by and between Abbott Laboratories, an Illinois corporation (? Parent?) and Alere Inc., a Delaware corporation (the ? Company?), is made by and among Parent, the Company and Angel Sub Inc., a Delaw |
|
| April 14, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8?K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2017 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1?16789 04?3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS E |
|
| April 14, 2017 |
Joint Press Release of Alere Inc. and Abbott Laboratories, dated April 14, 2017. EXHIBIT 99.1 News Release Abbott and Alere Amend Terms of Merger Agreement ABBOTT PARK, Ill. and WALTHAM, Mass., April 14, 2017 ? Abbott and Alere Inc. announced today that the companies have agreed to amend the existing terms of their agreement for Abbott's acquisition of Alere. Under the amended terms, Abbott will pay $51 per common share to acquire Alere, for a new expected equity value of appr |
|
| April 14, 2017 |
EXHIBIT 2.1 AMENDMENT TO AGREEMENT AND PLAN OF MERGER This AMENDMENT, dated as of April 13, 2017 (this ? Amendment?) to the Agreement and Plan of Merger (the ? Agreement?), dated as of January 30, 2016, by and between Abbott Laboratories, an Illinois corporation (? Parent?) and Alere Inc., a Delaware corporation (the ? Company?), is made by and among Parent, the Company and Angel Sub Inc., a Delaw |
|
| March 21, 2017 |
Alere Inc. Receives NYSE Notice Regarding Late Form 10-K Filing EX-99.1 Exhibit 99.1 Alere Inc. Receives NYSE Notice Regarding Late Form 10-K Filing WALTHAM, Mass., March 21, 2017 ? Alere Inc. (NYSE: ALR) (the ?Company?) announced today that, as a result of its failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2016 (the ?Form 10-K?), it has received a notice from the New York Stock Exchange (the ?NYSE?) that the Compa |
|
| March 21, 2017 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2017 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| March 15, 2017 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2017 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| March 1, 2017 |
NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For period ended: December 31, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on Form N-SAR For the transition period ended: If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: PART I REGISTRANT INFORMATION Alere Inc. |
|
| February 14, 2017 |
ALR / Alere Inc. / EdgePoint Investment Group Inc. - SC 13G/A Passive Investment SC 13G/A 1 d333089dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No. 4)* Under the Securities Exchange Act of 1934 Alere Inc. (Name of Issuer) Common Stock (Title of Class of |
|
| February 9, 2017 |
Alere 3G/A (Passive Acquisition of More Than 5% of Shares) alereinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3 )* Name of issuer: Alere Inc Title of Class of Securities: Common Stock CUSIP Number: 01449J105 Date of Event Which Requires Filing of this Statement: December 31, 2016 Check the appropriate box to designate the |
|
| February 7, 2017 |
ALR / Alere Inc. / Invesco Ltd. - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* Alere Inc (Name of Issuer) Common Stock (Title of Class of Securities) 01449J105 (CUSIP Number) December 30, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| February 2, 2017 |
JOINT FILING AGREEMENT This JOINT FILING AGREEMENT is made and entered into by and among Iridian Asset Management LLC, David L. |
|
| February 2, 2017 |
ALR / Alere Inc. / IRIDIAN ASSET MANAGEMENT LLC/CT Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Alere Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 01449J105 (CUSIP Number) December 31, 2016 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is f |
|
| December 13, 2016 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 8, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| November 7, 2016 |
Alere DEFINITIVE PROXY STATEMENT Definitive Proxy Statement Table of Contents SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12 Alere Inc. |
|
| November 4, 2016 |
Alere FORM 10-Q (Quarterly Report) Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| November 4, 2016 |
Alere Reports Third Quarter 2016 Financial Results EX-99.1 Exhibit 99.1 Alere Reports Third Quarter 2016 Financial Results WALTHAM, Mass., November 4, 2016 ? Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it has filed its Form 10-Q and reported financial results for the third quarter ended September 30, 2016. Revenue for the third quarter of 2016 was $582 million, a 4% decrease compared to $604 million in t |
|
| November 4, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| October 24, 2016 |
Alere Shareholders Approve Merger with Abbott Exhibit 99.1 Alere Shareholders Approve Merger with Abbott WALTHAM, Mass., October 21, 2016 ? Alere Inc. (NYSE: ALR) (the ?Company?), a global leader in rapid diagnostic tests, today announced that its shareholders have voted to approve previously announced merger with Abbott. In a final count of the voting results, over 98% of votes cast at a special meeting voted in favor of the merger, represen |
|
| October 24, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 21, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| October 20, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| October 3, 2016 |
DEFA14A 1 defa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rul |
|
| September 24, 2016 |
DEFM14A 1 d103445ddefm14a.htm DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as |
|
| September 19, 2016 |
PRER14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 19, 2016 |
SEC Response Letter September 19, 2016 VIA EDGAR Suzanne Hayes Assistant Director, Office of Healthcare and Insurance United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, N. |
|
| September 6, 2016 |
Alere Reports Second Quarter 2016 Financial Results Exhibit 99.1 Alere Reports Second Quarter 2016 Financial Results WALTHAM, Mass ., September 6, 2016 ? Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it has filed its Form 10-Q and reported its financial results for the second quarter ended June 30, 2016. Revenue for the second quarter of 2016 was $611 million, a 2% decrease compared to $623 million in the p |
|
| September 6, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8?K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 6, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1?16789 04?3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IR |
|
| September 2, 2016 |
Alere FORM 10-Q (Quarterly Report) 10-Q 1 d240144d10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period f |
|
| August 26, 2016 |
DEFA14A 1 defa14a.htm SCHEDULE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as per |
|
| August 26, 2016 |
DEFA14A 1 defa14a.htm SCHEDULE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as per |
|
| August 18, 2016 |
SECOND AMENDMENT TO CREDIT AGREEMENT Exhibit 10.1 SECOND AMENDMENT TO CREDIT AGREEMENT THIS SECOND AMENDMENT TO CREDIT AGREEMENT (this “ Second Amendment”), dated as of August 18, 2016, among ALERE INC., a Delaware corporation (the “ Borrower”), each of the Guarantors (as defined in the Credit Agreement referred to below) party hereto, the Lenders (as defined in the Credit Agreement referred to below) party hereto, GOLDMAN SACHS BANK |
|
| August 18, 2016 |
SECOND AMENDMENT TO CREDIT AGREEMENT Exhibit 10.1 SECOND AMENDMENT TO CREDIT AGREEMENT THIS SECOND AMENDMENT TO CREDIT AGREEMENT (this “ Second Amendment”), dated as of August 18, 2016, among ALERE INC., a Delaware corporation (the “ Borrower”), each of the Guarantors (as defined in the Credit Agreement referred to below) party hereto, the Lenders (as defined in the Credit Agreement referred to below) party hereto, GOLDMAN SACHS BANK |
|
| August 18, 2016 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8?K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1?16789 04?3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| August 18, 2016 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8?K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1?16789 04?3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| August 17, 2016 |
Alere 8-K/A (Current Report/Significant Event) 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (AMENDMENT NO. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Comm |
|
| August 17, 2016 |
Alere 8-K (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 17, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
| August 17, 2016 |
Alere Reports First Quarter 2016 Financial Results EX-99.1 Exhibit 99.1 Alere Reports First Quarter 2016 Financial Results WALTHAM, Mass., August 17, 2016 ? Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it has filed its Form 10-Q and reported its financial results for the first quarter ended March 31, 2016. Revenue for the first quarter of 2016 was $578 million, a 6% decrease compared to $613 million in th |
|
| August 17, 2016 |
EX-10.1 3 d127248dex101.htm EX-10.1 EXHIBIT 10.1 December 23, 2015 Jonathan Wygant 9975 Anderson Ranch Road Descanso CA 91916 Dear Jonathan: Congratulations and Welcome to Alere! We are pleased to offer you the position of Chief Accounting Office/Controller on behalf of Alere (the Company). We are excited that you have chosen to join forces with us as we build the OneAlere culture. We are confiden |
|
| August 17, 2016 |
2016 Annual Incentive Plan February 2016 EX-10.3 Exhibit 10.3 2016 Annual Incentive Plan February 2016 Primary Objective: the primary objective of the plan to assist in the attraction, retention and motivation of the senior talent critical to deliver on the Strategic Imperatives in 2016, and particularly those that consistently demonstrate the competencies and values that serve as the foundation for One Alere and its culture. Performance |
|
| August 17, 2016 |
CHANGE OF CONTROL SEVERANCE AGREEMENT EX-10.2 Exhibit 10.2 CHANGE OF CONTROL SEVERANCE AGREEMENT This CHANGE OF CONTROL SEVERANCE AGREEMENT (the “Agreement” or “Severance Agreement”), dated as of the date set forth below (“Effective Date”) between Jonathan Wygant (“Employee”) and Alere Inc. (the “Company”), provides: WHEREAS, in order to accomplish its objectives, the Company believes it is essential that certain of its executives, su |
|
| August 17, 2016 |
AMENDED AND RESTATED ALERE INC. (the “Corporation”) ARTICLE I EX-3.1 Exhibit 3.1 AMENDED AND RESTATED BY-LAWS OF ALERE INC. (the “Corporation”) ARTICLE I Stockholders SECTION 1. Annual Meeting. The annual meeting of stockholders (any such meeting being referred to in these By-laws as an “Annual Meeting”) shall be held at the hour, date and place within or without the United States which is fixed by the Board of Directors, which time, date and place may subse |
|
| August 16, 2016 |
10-Q 1 d127248d10q.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from |
|
| August 15, 2016 |
PREM14A 1 d103445dprem14a.htm PREM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as |
|
| August 15, 2016 |
PREM14A 1 d103445dprem14a.htm PREM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as |
|
| August 10, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8?K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1?16789 04?3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| August 10, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For period ended: June 30, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on Form N-SAR For the transition period ended: If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: PART I REGISTRANT INFORMATION Alere Inc. |
|
| August 8, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8‑K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1‑16789 04‑3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS E |
|
| August 8, 2016 |
Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results Exhibit 99.1 Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results WALTHAM, Mass ., August 8, 2016 – Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it has filed its Form 10-K and reported its financial results for the fourth quarter and full year ended December 31, 2015. The Company also announced that it concluded the analysis |
|
| August 8, 2016 |
Alere FORM 10-K (Annual Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 Commission file number 000-16789 ALERE INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 04-3565120 (State or other jurisdiction of incorporation or or |
|
| August 8, 2016 |
TWENTY-SECOND SUPPLEMENTAL INDENTURE EX-4.8 3 d78820dex48.htm EX-4.8 Exhibit 4.8 TWENTY-SECOND SUPPLEMENTAL INDENTURE TWENTY-SECOND SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of September 15, 2015, among INSTANT TECH SUBSIDIARY ACQUISITION INC. (the “New Guarantor”), which is a Subsidiary of Alere Inc. (the “Issuer”), ALERE INC., a Delaware corporation, each of the existing Guarantors (the “Existing Guarantors”) |
|
| August 8, 2016 |
EX-21.1 Exhibit 21.1 List of Subsidiaries of Alere Inc. Name of Subsidiary State or Jurisdiction of Incorporation % of ownership Amedica Biotech, Inc. California 100 % Ameditech Inc. California 100 % Redwood Toxicology Laboratory, Inc. California 100 % Alere Connect, LLC Delaware 100 % Alere Holdco, Inc. Delaware 100 % Alere Home Monitoring, Inc. Delaware 100 % Alere International Holding Corp. De |
|
| August 8, 2016 |
NINETEENTH SUPPLEMENTAL INDENTURE EX-4.14 4 d78820dex414.htm EX-4.14 Exhibit 4.14 NINETEENTH SUPPLEMENTAL INDENTURE NINETEENTH SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of September 15, 2015, among INSTANT TECH SUBSIDIARY ACQUISITION INC. (the “New Guarantor”), which is a Subsidiary of Alere Inc. (the “Issuer”), ALERE INC., a Delaware corporation, each of the existing Guarantors (the “Existing Guarantors”) u |
|
| August 8, 2016 |
TWENTY-THIRD SUPPLEMENTAL INDENTURE EX-4.6 Exhibit 4.6 TWENTY-THIRD SUPPLEMENTAL INDENTURE TWENTY-THIRD SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of September 15, 2015, among INSTANT TECH SUBSIDIARY ACQUISITION INC. (the “New Guarantor”), which is a Subsidiary of Alere Inc. (the “Issuer”), ALERE INC., a Delaware corporation, each of the existing Guarantors (the “Existing Guarantors”) under the Indenture referr |
|
| August 8, 2016 |
EX-10.14 Exhibit 10.14 December 31, 2014 Ms. Renuka Uppaluri 2308 Wynonna Ct. Louisville, CO 80027 Re: Offer of Employment Dear Renuka: I am very pleased to extend to you this offer to become a full time employee of Alere, Inc, (the Company) as our Senior Vice President, Global R&D, based in our San Diego facility, and reporting to Namal Nawana, President and Chief Executive Officer. Your start da |
|
| July 14, 2016 |
Alere (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 14, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Em |
|
| July 14, 2016 |
Alere Inc. Announces Update on Form 10-K Exhibit 99.1 Alere Inc. Announces Update on Form 10-K WALTHAM, Mass., July 14, 2016 – Alere Inc. (NYSE: ALR) (the “ Company”) announced today certain preliminary unaudited financial information for the fiscal year ended December 31, 2015 and the three months ended March 31, 2016. The Company also provided an update on its plans for its upcoming Annual Report on Form 10-K for 2015 (the “ 2015 Form |
|
| July 12, 2016 |
Financial Statements and Exhibits, Material Impairments UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Em |
|
| July 12, 2016 |
Alere to Initiate Voluntary Withdrawal of the Alere INRatio® and INRatio®2 PT/INR Monitoring System EX-99.1 2 d225623dex991.htm EX-99.1 Exhibit 99.1 Alere to Initiate Voluntary Withdrawal of the Alere INRatio® and INRatio®2 PT/INR Monitoring System WALTHAM, Mass., July 11, 2016 – Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc. (NYSE:ALR) will be initiating a voluntary withdrawal of the Alere INRatio® and INRatio®2 PT/INR Monitoring System. Alere is |
|
| May 31, 2016 |
Alere Inc. Conflict Minerals Report For The Year Ended December 31, 2015 EX-1.01 Exhibit 1.01 Alere Inc. Conflict Minerals Report For The Year Ended December 31, 2015 This Conflict Minerals Report of Alere Inc., including its consolidated subsidiaries (herein referred to as ?Alere,? the ?Company,? ?we,? ?us,? or ?our?), for the year ended December 31, 2015 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the ?1934 Act?). The Rule was ad |
|
| May 31, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ALERE INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation or Organization) (Commission File Number) (I.R.S. Employer Identification No.) 51 Sawyer Road, Suite 200, Waltham, Massachusetts 02459 (Address of Pri |
|
| May 11, 2016 |
NT 10-Q 1 nt10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) ☐ Form 10-K ☐ Form 20-F ¨ Form 11-K x Form 10-Q ☐ Form 10-D ¨ Form N-SAR ☐ Form N-CSR For period ended: March 31, 2016 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Tran |
|
| May 10, 2016 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Emp |
|
| May 10, 2016 |
Alere Inc. Announces Successful Completion of Consent Solicitations for Alere’s Notes EX-99.1 2 ex99-1.htm Exhibit 99.1 Alere Inc. Announces Successful Completion of Consent Solicitations for Alere’s Notes WALTHAM, Mass., May 10, 2016 – Alere Inc. (NYSE: ALR) (the “Company”) announced today the successful completion of the previously announced consent solicitations relating to the Company’s 6.500% Senior Subordinated Notes due 2020, 6.375% Senior Subordinated Notes due 2023 and 7.2 |
|
| April 29, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| April 28, 2016 |
FIRST AMENDMENT TO CREDIT AGREEMENT EX-10.1 2 ex10-1.htm Exhibit 10.1 FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO CREDIT AGREEMENT (this “First Amendment”), dated as of April 22, 2016, among ALERE INC., a Delaware corporation (the “Borrower”), each of the Guarantors (as defined in the Credit Agreement referred to below) party hereto, the Lenders (as defined in the Credit Agreement referred to below) party hereto, GOL |
|
| April 28, 2016 |
Alere (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS E |
|
| April 19, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS E |
|
| April 4, 2016 |
Alere CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1?16789 04?3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Em |
|
| March 21, 2016 |
Alere CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8?K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1?16789 04?3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS E |
|
| March 21, 2016 |
Alere Inc. Receives NYSE Notice Regarding Late Form 10-K Filing Exhibit 99.1 Alere Inc. Receives NYSE Notice Regarding Late Form 10-K Filing WALTHAM, Mass., March 21, 2016 – Alere Inc. (NYSE: ALR) (the “Company”) announced today that, as a result of its failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2015 (the “Form 10-K”), it has received a notice from the New York Stock Exchange (the “NYSE”) that the Company is no |
|
| March 14, 2016 |
Alere (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8?K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 11, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1?16789 04?3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS E |
|
| March 14, 2016 |
DEFA14A 1 form8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8‑K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 11, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1‑16789 04‑3565120 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| March 10, 2016 |
ALR / Alere Inc. / SCOPIA CAPITAL MANAGEMENT LP - FORM SC 13G/A Passive Investment SC 13G/A 1 e68630sc13ga.htm FORM SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Alere Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 01449J105 (CUSIP Number) February 29, 2016 (Date of Event Which Requires Filing of this Statement) Check the appro |
|
| March 2, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 25, 2016 Alere Inc. (Exact name of registrant as specified in its charter) Delaware 001-16789 04-3565120 (State or other jurisdiction of incorporation) (Commission file numbe |
|
| February 26, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For period ended: December 31, 2015 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on Form N-SAR For the transition period ended: If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: PART I REGISTRANT INFORMATION Alere Inc. |
|
| February 16, 2016 |
Alere SC 13G/A (Passive Acquisition of More Than 5% of Shares) SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No. 3)* Under the Securities Exchange Act of 1934 Alere Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 01449J105 (CUSIP |
|
| February 16, 2016 |
ALR / Alere Inc. / SCOPIA CAPITAL MANAGEMENT LP Passive Investment STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 12, 2016 |
Form S-8 As filed with the Securities and Exchange Commission on February 12, 2016 Registration Statement No. |
|
| February 12, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| February 12, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| February 11, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant : ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Def |
|
| February 10, 2016 |
ALR / Alere Inc. / VANGUARD GROUP INC Passive Investment SC 13G/A 1 alereinc.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2 )* Name of issuer: Alere Inc Title of Class of Securities: Common Stock CUSIP Number: 01449J105 Date of Event Which Requires Filing of this Statement: December 31, 2015 Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 3, 2016 |
ALR / Alere Inc. / Invesco Ltd. - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Alere Inc (Name of Issuer) Common Stock (Title of Class of Securities) 01449J105 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate |
|
| February 1, 2016 |
Exhibit 3.1 ALERE INC. BY-LAW AMENDMENT The Amended and Restated By-laws of Alere Inc. are hereby amended to add a new Article VII, as set forth below: ?ARTICLE VII FORUM FOR ADJUDICATION OF DISPUTES. Unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Corporation, (ii |
|
| February 1, 2016 |
EX-99.1 4 ex99-1.htm Exhibit 99.1 News Release Abbott to Acquire Alere, Becoming Leader in Point of Care Testing and Significantly Advancing Global Diagnostics Presence ABBOTT GAINS LEADERSHIP IN THE $5.5 BILLION POINT OF CARE SEGMENT, BROADENS DIAGNOSTICS FOOTPRINT AND ENHANCES ACCESS TO FAST-GROWING DIAGNOSTICS CHANNELS ● Transaction expected to be immediately accretive to Abbott’s ongoing earni |
|
| February 1, 2016 |
Exhibit 3.1 ALERE INC. BY-LAW AMENDMENT The Amended and Restated By-laws of Alere Inc. are hereby amended to add a new Article VII, as set forth below: ?ARTICLE VII FORUM FOR ADJUDICATION OF DISPUTES. Unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Corporation, (ii |
|
| February 1, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| February 1, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| February 1, 2016 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER By and Among ABBOTT LABORATORIES and ALERE INC. Dated as of January 30, 2016 TABLE OF CONTENTS Page ARTICLE I The Merger SECTION 1.01. The Merger 2 SECTION 1.02. Closing 2 SECTION 1.03. Effective Time 2 SECTION 1.04. Effects of the Merger 2 SECTION 1.05. Certificate of Incorporation of the Surviving Corporation 2 SECTION 1.06. Directors and Officers of the |
|
| February 1, 2016 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER By and Among ABBOTT LABORATORIES and ALERE INC. Dated as of January 30, 2016 TABLE OF CONTENTS Page ARTICLE I The Merger SECTION 1.01. The Merger 2 SECTION 1.02. Closing 2 SECTION 1.03. Effective Time 2 SECTION 1.04. Effects of the Merger 2 SECTION 1.05. Certificate of Incorporation of the Surviving Corporation 2 SECTION 1.06. Directors and Officers of the |
|
| February 1, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| February 1, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| February 1, 2016 |
Exhibit 99.1 News Release Abbott to Acquire Alere, Becoming Leader in Point of Care Testing and Significantly Advancing Global Diagnostics Presence ABBOTT GAINS LEADERSHIP IN THE $5.5 BILLION POINT OF CARE SEGMENT, BROADENS DIAGNOSTICS FOOTPRINT AND ENHANCES ACCESS TO FAST-GROWING DIAGNOSTICS CHANNELS ? Transaction expected to be immediately accretive to Abbott?s ongoing earnings per share upon cl |
|
| February 1, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| January 11, 2016 |
EX-99.1 2 d118365dex991.htm EX-99.1 Namal Nawana | CEO and President 34th Annual JP Morgan Healthcare Conference San Francisco, January 11, 2016 © 2015 Alere Inc. Namal Nawana, CEO and President Exhibit 99.1 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the federal securities laws. This includes all statements concerning or relating to our a |
|
| January 11, 2016 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 11, 2016 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| December 3, 2015 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 30, 2015 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| November 13, 2015 |
10-K/A 1 d78896d10ka.htm FORM 10-K/A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 3) ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 Commission file number 000-16789 ALERE INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 04-35 |
|
| November 9, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBE |
|
| November 6, 2015 |
Results of Operations and Financial Condition Form 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2015 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) |
|
| November 4, 2015 |
Alere FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2015 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| November 4, 2015 |
Alere Reports Third Quarter 2015 Financial Results EX-99.1 Exhibit 99.1 Alere Reports Third Quarter 2015 Financial Results WALTHAM, Mass., November 4, 2015 ? Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced its financial results for the quarter ended September 30, 2015. Net revenue for the third quarter of 2015 was $602.0 million, a 7.3 percent decrease compared to $649.2 million in the third quarter of 2014, or a |
|
| October 6, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2015 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| October 6, 2015 |
SEVERANCE AGREEMENT AND RELEASE EX-10.1 Exhibit 10.1 SEVERANCE AGREEMENT AND RELEASE THIS SEVERANCE AGREEMENT AND RELEASE is made by and between Alere Inc. (?Alere,? and together with its subsidiaries and affiliated companies, the ?Company?) and David Teitel (?Employee?), an individual residing at 6 Ledgestone Drive, Hopkinton, MA 01748-2695. WHEREAS, Employee was employed by Alere in Waltham, Massachusetts; WHEREAS, Alere has e |
|
| August 6, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER 001 |
|
| August 4, 2015 |
Alere FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2015 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| August 4, 2015 |
EX-99.1 Exhibit 99.1 Alere Reports Second Quarter 2015 Financial Results Organic Growth of 3.5% Driven by New and Existing Product Sales across Core Portfolio ? Net revenue of $629.2 million; non-GAAP adjusted net revenue of $629.4 million ? Organic revenue growth was 3.5 percent; excluding North America influenza sales, organic revenue growth was 3.3 percent ? $0.17 income per diluted share avail |
|
| July 23, 2015 |
Submission of Matters to a Vote of Security Holders 8-K 1 d145123d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2015 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (C |
|
| July 14, 2015 |
SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12 Alere Inc. |
|
| July 2, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 2, 2015 Alere Inc. (Exact name of registrant as specified in its charter) Delaware 001-16789 04-3565120 (State or other jurisdiction of incorporation) (Commission file number) (I |
|
| July 2, 2015 |
DEFA14A SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement x Definitive Additional Materials ? Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12 Alere Inc. |
|
| July 1, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 30, 2015 Alere Inc. (Exact name of registrant as specified in its charter) Delaware 001-16789 04-3565120 (State or other jurisdiction of incorporation) (Commission file number) ( |
|
| July 1, 2015 |
DEFA14A 1 d37772ddefa14a.htm DEFA14A SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of the Commission Only (as permitted |
|
| June 24, 2015 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Juliet Cunningham, Vice President, Investor Relations, [email protected], 858.805.2232 Alere Inc. Announces Completion of Offering of $425 Million of Senior Subordinated Notes WALTHAM, Mass., June 24, 2015 ? Alere Inc. (NYSE: ALR) (the ?Company?) announced today that it has completed its previously announced offering of $425 million of senior subordinated not |
|
| June 24, 2015 |
EX-4.1 Exhibit 4.1 EXECUTION VERSION ALERE INC., as Issuer, the GUARANTORS named herein, as Guarantors, and U.S. BANK NATIONAL ASSOCIATION, as Trustee TWENTY-FIRST SUPPLEMENTAL INDENTURE Dated as of June 24, 2015 6.375% Senior Subordinated Notes due 2023 TABLE OF CONTENTS Page ARTICLE ONE ESTABLISHMENT; DEFINITIONS AND INCORPORATION BY REFERENCE SECTION 1.01 Establishment 2 SECTION 1.02 Definition |
|
| June 24, 2015 |
EX-10.1 3 d948919dex101.htm EX-10.1 Exhibit 10.1 EXECUTION VERSION CREDIT AGREEMENT Dated as of June 18, 2015 among ALERE INC., as Borrower, THE LENDERS AND L/C ISSUERS PARTY HERETO, GOLDMAN SACHS BANK USA, as B Term Loan Administrative Agent, GENERAL ELECTRIC CAPITAL CORPORATION, as Collateral Agent and Pro Rata Administrative Agent, GENERAL ELECTRIC CAPITAL CORPORATION, as Syndication Agent and |
|
| June 24, 2015 |
Exhibit 10.2 GUARANTY AND SECURITY AGREEMENT Dated as of June 18, 2015 among Alere Inc., as Borrower, and Each Other Grantor From Time to Time Party Hereto and GENERAL ELECTRIC CAPITAL CORPORATION, as Collateral Agent TABLE OF CONTENTS ARTICLE I DEFINED TERMS 1 Section 1.1 Definitions 1 Section 1.2 Certain Other Terms 4 ARTICLE II GUARANTY 4 Section 2.1 Guaranty 4 Section 2.2 Limitation of Guarant |
|
| June 24, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 18, 2015 Alere Inc. (Exact name of registrant as specified in its charter) Delaware 001-16789 04-3565120 (State or other jurisdiction of incorporation) (Commission file |
|
| June 16, 2015 |
Alere Inc. Announces Offering of $425 Million of Senior Subordinated Notes EX-99.1 Exhibit 99.1 Alere Inc. Announces Offering of $425 Million of Senior Subordinated Notes WALTHAM, Mass., June 10, 2015 ? Alere Inc. (NYSE: ALR) (the ?Company?) announced today that it intends to offer $425 million of senior subordinated notes due 2023 through a private placement. The Company intends to use the net proceeds from the offering to redeem its outstanding $400 million aggregate p |
|
| June 16, 2015 |
Alere Inc. Announces Pricing of $425 Million Senior Subordinated Notes Offering EX-99.2 4 d942755dex992.htm EX-99.2 Exhibit 99.2 Alere Inc. Announces Pricing of $425 Million Senior Subordinated Notes Offering WALTHAM, Mass., June 11, 2015 – Alere Inc. (NYSE: ALR) (the “Company”) announced today that, in connection with its previously announced private placement of $425 million of senior subordinated notes due 2023, it entered into a purchase agreement with the initial purchas |
|
| June 16, 2015 |
Alere Inc. $425,000,000 6.375% Senior Subordinated Notes due 2023 PURCHASE AGREEMENT EX-10.1 Exhibit 10.1 EXECUTION VERSION Alere Inc. $425,000,000 6.375% Senior Subordinated Notes due 2023 PURCHASE AGREEMENT June 11, 2015 J.P. MORGAN SECURITIES LLC As Representative of the several Initial Purchasers c/o 383 Madison Avenue New York, New York, 10179 Ladies and Gentlemen: Introductory. Alere Inc., a Delaware corporation (the ?Company?), proposes to issue and sell to the several init |
|
| June 16, 2015 |
Alere 8-K (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 10, 2015 Alere Inc. (Exact name of registrant as specified in its charter) Delaware 001-16789 04-3565120 (State or other jurisdiction of incorporation) (Commission file numbe |
|
| June 12, 2015 |
DEF 14A Table of Contents SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12 Alere Inc. |
|
| June 12, 2015 |
DEFA14A SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement x Definitive Additional Materials ? Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12 Alere Inc. |
|
| May 29, 2015 |
Alere Inc. Conflict Minerals Report For The Year Ended December 31, 2014 EX-1.01 Exhibit 1.01 Alere Inc. Conflict Minerals Report For The Year Ended December 31, 2014 This Conflict Minerals Report of Alere Inc., including its consolidated subsidiaries (herein referred to as ?Alere? the ?Company,? ?we,? ?us,? or ?our?), for the year ended December 31, 2014 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the ?1934 Act?). The Rule was ado |
|
| May 29, 2015 |
Form SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation or Organization) (Commission File Number) (IRS Employer Identification No.) 51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453 (Address of Pr |
|
| May 28, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2015 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 28, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER 00 |
|
| May 28, 2015 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 2) ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 Commission file number 000-16789 ALERE INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 04-3565120 (State or other jurisdiction of |
|
| May 28, 2015 |
EX-99.1 Exhibit 99.1 Alere Inc. and Subsidiaries Condensed Consolidated Statements of Operations (in thousands, except per share amounts) Three Months Ended March 31, 2015 2014 Net product sales and services revenue $ 603,455 $ 620,027 License and royalty revenue 4,698 5,212 Net revenue 608,153 625,239 Cost of net revenue 316,168 314,881 Gross profit 291,985 310,358 Gross margin 48 % 50 % Operatin |
|
| May 28, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COM |
|
| May 26, 2015 |
Alere FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2015 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 26, 2015 |
Alere Inc. Receives NYSE Notice Regarding Late Form 10-Q Filing EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Juliet Cunningham, Vice President, Investor Relations, [email protected], 858.805.2232 Alere Inc. Receives NYSE Notice Regarding Late Form 10-Q Filing WALTHAM, Mass., May 26, 2015 ? Alere Inc. (NYSE: ALR) (the ?Company?) announced today that, as a result of its failure to timely file its Quarterly Report on Form 10-Q for the three months ended March 3 |
|
| May 12, 2015 |
NT 10-Q SEC FILE NUMBER: 001-16789 CUSIP NUMBER: 01449J105 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 5, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2015 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 5, 2015 |
Alere Reports Preliminary First Quarter 2015 Financial Results and Announces 2014 Restatement EX-99.1 Exhibit 99.1 Alere Reports Preliminary First Quarter 2015 Financial Results and Announces 2014 Restatement ? Net revenue of $610.4 million; non-GAAP adjusted net revenue of $610.7 million ? Total organic revenue growth was 2.6 percent; excluding North America influenza sales, organic growth was 0.5 percent ? $0.11 loss per diluted share available to common stockholders from continuing oper |
|
| April 30, 2015 |
Exhibit 10.23 March 8, 2013 Ms. Daniella Cramp Alere San Diego, Inc. 9975 Summers Ridge Road San Diego, CA 92121 Dear Daniella: I am pleased that you have agreed to continue your employment within the Alere group of companies in the new role of Global President Chronic Care for Alere Inc. (“Alere” or the “Company”). In this position, you will report to Namal Nawana, Alere’s Chief Operating Officer |
|
| April 30, 2015 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 Commission file number 000-16789 ALERE INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 04-3565120 (State or other jurisdiction of |
|
| April 30, 2015 |
Exhibit 10.22 October 24, 2014 Mr. Namal Nawana 33 Westcliff Road Weston, MA 02493 Dear Namal: I am pleased to extend to you this offer to become a Chief Executive Officer of Alere, Inc, (the Company) and a member of the Company?s Board of Directors. This offer contains the following terms: Base Compensation: You will receive a biweekly salary of $40,384.62, or $1,050,000.00 annualized, effective |
|
| April 29, 2015 |
ALERE INC. 2010 STOCK OPTION AND INCENTIVE PLAN EX-10.1 Exhibit 10.1 ALERE INC. 2010 STOCK OPTION AND INCENTIVE PLAN SECTION 1. GENERAL PURPOSE OF THE PLAN; DEFINITIONS The name of the plan is the Alere Inc. 2010 Stock Option and Incentive Plan (the ?Plan?). The purpose of the Plan is to encourage and enable the officers, employees, Independent Directors and other key persons (including consultants) of Alere Inc. (the ?Company?) and its Subsidi |
|
| April 29, 2015 |
Alere FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2015 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| April 9, 2015 |
Form S-8 As filed with the Securities and Exchange Commission on April 9, 2015 Registration Statement No. |
|
| April 9, 2015 |
- 1 - 51 Sawyer Rd., Suite 200 Waltham, MA 02453 phone 781-647-3900 fax 781-647-3939 EX-4.1 Exhibit 4.1 51 Sawyer Rd., Suite 200 Waltham, MA 02453 phone 781-647-3900 fax 781-647-3939 March 19, 2015 Mr. James F. Hinrichs P.O. Box 7043 Rancho Santa Fe, CA 92067 Re: Offer of Employment Dear Jim: I am very pleased to extend to you this offer to become a full-time employee of Alere, Inc. (the Company) as its Chief Financial Officer and Executive Vice President, based in our San Diego f |
|
| March 23, 2015 |
Alere 8-K (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 19, 2015 Alere Inc. (Exact name of registrant as specified in its charter) Delaware 001-16789 04-3565120 (State or other jurisdiction of incorporation) (Commission file numb |
|
| March 9, 2015 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 9, 2015 ALERE INC. (Exact name of registrant as specified in charter) Delaware 1-16789 04-3565120 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IR |
|
| March 5, 2015 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 Commission file number 000-16789 ALERE INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 04-3565120 (State or other jurisdiction of incorporation or or |
|
| March 5, 2015 |
Exhibit 21.1 List of Subsidiaries of Alere Inc. Name of Subsidiary State or Jurisdiction of Incorporation % of ownership ABON Biopharm (Hangzhou) Co., Ltd. China 100 % AdnaGen GmbH Germany 100 % Alere AB (formerly Medinor AB) Sweden 100 % Alere Analytics, Inc. Delaware 100 % Alere Connect, LLC Delaware 100 % Alere AS (formerly Medinor AS) Norway 100 % Alere AS Holdings Limited England and Wales 10 |
